Listar por autor "Sanmartí, Raimon"
Mostrando ítems 1-6 de 6
-
Blood RNA sequencing reveals immunological processes associated with the response to abatacept in rheumatoid arthritis.
Julià, Antonio; López Lasanta, María; Gómez, Antonio; Sanmartí, Raimon; Marras, Carlos; Pina Salvador, José Manuel; Romero Yuste, Susana; Veiga Cabello, Raúl María; Navarro, Pilar; Moragues Pastor, Carme; Martínez Pardo, Silvia; De-Toro, Javier; Sánchez, Amalia; Cerda, Dacia; Prada, Alejandro; Erra, Alba; Monfort, Jordi; Urruticoechea-Arana, Ana; Palau, Núria; Lastra, Raquel M.; Tortosa, Raúl; Pluma Sanjurjo, Andrea; Marsal, Sara (BMJ Journals, 2019-05-27) -
Clinical, patient-reported, and ultrasound outcomes from an open-label, 12-week observational study of certolizumab pegol in spanish patients with rheumatoid arthritis with or without prior anti-TNF exposure
Blanco García, Francisco J; Rubio-Romero, Esteban; Sanmartí, Raimon; Díaz-Torné, César; Talavera, Pablo; Dunkel, Jochen; Naredo, Esperanza (Elsevier, 2018-09-17)[Abstract] Objectives: To assess the effectiveness and safety of certolizumab pegol (CZP) in Spanish patients with RA. Materials and methods: SONAR (NCT01526434), a 12-week, open-label, prospective, observational, ... -
Expert recommendations on the interleukin 6 blockade in patients with rheumatoid arthritis
Tornero Molina, Jesús; Balsa Criado, Alejandro; Blanco García, Francico J; Blanco Alonso, Ricardo; Bustabad, Sagrario; Calvo Alen, Jaime; Corominas, Héctor; Fernández Nebro, Antonio; Román Ivorra, José Andrés; Sanmartí, Raimon (Elsevier, 2020-07)[Abstract] Objective: To draft recommendations on interleukin 6 (IL-6) blockade in rheumatoid arthritis (RA), based on best evidence and experience. Methods: A group of 10 experts on IL-6 blockade in RA was selected. ... -
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Juliá, Antonio; López-Lasanta, María; Blanco García, Francisco J; Gómez, Antonio; Haro, Isabel; juan Más, Antonio; Erra, Alba; García-Vivar, María L.; Monfort, Jordi; Sánchez-Fernández, Simón; González, Isidoro; Alperi-López, Mercedes; Castellanos-Moreira, Raúl; Fernández-Nebro, Antonio; Díaz-Torné, César; Lastra, Raquel M.; Lladós, Jordi; Palau, Núria; Sanmartí, Raimon; Marsal, Sara (Springer, 2021-04-21)[Abstract] Background. Blocking of the Tumor Necrosis Factor (TNF) activity is a successful therapeutic approach for 50–60% of rheumatoid arthritis (RA) patients. However, there are yet no biomarkers to stratify patients ... -
Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis
Juliá, Antonio; Gómez, Antonio; López-Lasanta, María; Blanco García, Francisco J; Erra, Alba; Fernández-Nebro, Antonio; Juan Mas, Antonio; Pérez-García, Carolina; García Vivar, María Luz; Sánchez-Fernández, Simón; Alperi-López, Mercedes; Sanmartí, Raimon; Ortiz, Ana María; Marras Fernández-Cid, Carlos; Díaz-Torné, César; Moreno, Estefanía; Li, Tianlu; Martínez-Mateu, Sergio H.; Absher, Devin M.; Myers, Richard M.; Tornero Molina, Jesús; Marsal, Sara (Elsevier, 2022-05-13)[Abstract] Background: Rheumatoid arthritis (RA) is a chronic, immune-mediated inflammatory disease of the joints that has been associated with variation in the peripheral blood methylome. In this study, we aim to identify ... -
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
González-Álvaro, Isidoro; Martínez-Fernández, Carmen; Dorantes-Calderón, Benito; García-Vicuña, Rosario; Hernández-Cruz, Blanca; Herrero-Ambrosio, Alicia; Ibarra-Barrueta, Olatz; Martín-Mola, Emilio; Monte-Boquet, Emilio; Morell-Baladrón, Alberto; Sanmartí, Raimon; Sanz-Sanz, Jesús; De-Toro, Javier; Vela, Paloma; Román Ivorra, José Andrés; Poveda-Andrés, José Luis; Muñoz-Fernández, Santiago (Oxford University Press, 2014-12-19)[Abstract] Objective. The aim of this study was to establish guidelines for the optimization of biologic therapies for health professionals involved in the management of patients with RA, AS and PsA. Methods. Recommendations ...